文献速递乳腺US乳腺X线

中国女性乳腺癌筛查中基于超声策略的基线性能

Baseline Performance of Ultrasound-Based Strategies in Breast Cancer Screening Among Chinese Women.
PubMed 文献 · Acad Radiol · 2024-08-22

这项前瞻性队列研究于2018年10月至2022年8月在中国中部纳入8996名35–64岁女性,分35–44岁和45–64岁两组,分别用手持超声(HHUS)和自动乳腺超声系统(ABUS)筛查,高龄组加做全视野数字乳腺X线摄影(FFDM)。35–44岁组HHUS与ABUS的AUC无显著差异(0.8678 vs. 0.8679,P>0.05);45–64岁组ABUS单独策略AUC 0.9935、HHUS联合FFDM AUC 0.9920、ABUS联合FFDM AUC 0.9928均优于FFDM单独(AUC 0.8983,P<0.05)。结论认为HHUS和ABUS作为独立筛查策略表现良好,ABUS潜力更优,但FFDM与超声技术联合并未显著提升筛查整体效果。

要点

  • 45–64岁组ABUS单独策略AUC 0.9935,优于FFDM单独AUC 0.8983(P<0.05)。
  • 35–44岁组HHUS与ABUS的AUC无显著差异(0.8678 vs. 0.8679,P>0.05)。
  • 45–64岁组HHUS单独与FFDM单独的AUC无显著差异(0.9529 vs. 0.8983,P>0.05)。

核心结论

  • HHUS和ABUS作为独立乳腺癌筛查策略均表现良好,ABUS潜力更优;但FFDM与超声技术联合并未显著提升筛查整体效果。

研究设计与样本

  • 前瞻性队列研究,2018年10月至2022年8月在中国中部纳入8996名35–64岁女性,分35–44岁和45–64岁两组,使用HHUS和ABUS筛查,高龄组加做FFDM,以BI-RADS分类判读。

诊断标准与关键数值

  • 以BI-RADS 4/5为异常需活检,BI-RADS 3需在6–12个月内随访,BI-RADS 1/2为阴性;35–44岁组HHUS与ABUS的AUC分别为0.8678和0.8679(P>0.05)。

临床应用与阅片要点

  • 45–64岁组ABUS单独策略AUC 0.9935,HHUS联合FFDM AUC 0.9920,ABUS联合FFDM AUC 0.9928,均优于FFDM单独AUC 0.8983(P<0.05);HHUS单独AUC 0.9529与FFDM单独AUC 0.8983无显著差异(P>0.05)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVE: There is a notable absence of robust evidence on the efficacy of ultrasound-based breast cancer screening strategies, particularly in populations with a high prevalence of dense breasts. Our study addresses this gap by evaluating the effectiveness of such strategies in Chinese women, thereby enriching the evidence base for identifying the most efficacious screening approaches for women with dense breast tissue.

METHODS: Conducted from October 2018 to August 2022 in Central China, this prospective cohort study enrolled 8996 women aged 35-64 years, divided into two age groups (35-44 and 45-64 years). Participants were screened for breast cancer using hand-held ultrasound (HHUS) and automated breast ultrasound system (ABUS), with the older age group also receiving full-field digital mammography (FFDM). The Breast Imaging Reporting and Data System (BI-RADS) was employed for image interpretation, with abnormal results indicated by BI-RADS 4/5, necessitating a biopsy; BI-RADS 3 required follow-up within 6-12 months by primary screening strategies; and BI-RADS 1/2 were classified as negative.

RESULTS: Among the screened women, 29 cases of breast cancer were identified, with 4 (1.3‰) in the 35-44 years age group and 25 (4.2‰) in the 45-64 years age group. In the younger age group, HHUS and ABUS performed equally well, with no significant difference in their AUC values (0.8678 vs. 0.8679, P > 0.05). For the older age group, ABUS as a standalone strategy (AUC 0.9935) and both supplemental screening methods (HHUS with FFDM, AUC 0.9920; ABUS with FFDM, AUC 0.9928) outperformed FFDM alone (AUC 0.8983, P < 0.05). However, there was no significant difference between HHUS alone and FFDM alone (AUC 0.9529 vs. 0.8983, P > 0.05).

CONCLUSION: The findings indicate that both HHUS and ABUS exhibit strong performance as independent breast cancer screening strategies, with ABUS demonstrating superior potential. However, the integration of FFDM with these ultrasound techniques did not confer a substantial improvement in the overall effectiveness of the screening process.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Xu HF, Wang H, Liu Y, et al. Baseline Performance of Ultrasound-Based Strategies in Breast Cancer Screening Among Chinese Women. Acad Radiol. 2024. PMID: 39174359. doi:10.1016/j.acra.2024.07.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。